Hartmut Tintrup
Directeur Général chez Cellbox Solutions GmbH
Profil
Hartmut Tintrup is currently the Chief Executive Officer at Cellbox Solutions GmbH since 2023.
Prior to this, he worked as the Director-Industrial Markets at amaxa GmbH, Principal at Exelixis, Inc., Chief Business Officer at CEVEC Pharmaceuticals GmbH from 2012 to 2015, Research Scientist at Taconic Biosciences GmbH, and Manager-Tactical Marketing & Export at Lonza Cologne AG.
He holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main, which he received in 1988.
Postes actifs de Hartmut Tintrup
| Sociétés | Poste | Début |
|---|---|---|
Cellbox Solutions GmbH
 Cellbox Solutions GmbH Information Technology ServicesTechnology Services Cellbox Solutions GmbH provides innovative logistics solutions for the healthcare industry to transport sensitive biological material and therapeutics that suffer from freezing during shipment but require optimal physiological conditions when transported. The company is based in Cologne, Germany. The German company's portable CO2 incubator, Cellbox, provides a controlled and optimal environment for the transport of living cells, organoids, tissues, and other sensitive biological material. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions. The company was founded in 2017 by Kathrin Adlkofer. Wolfgang Kintzel has been the CEO of the company since 2020. | Directeur Général | 01/11/2023 |
Anciens postes connus de Hartmut Tintrup
| Sociétés | Poste | Fin |
|---|---|---|
amaxa GmbH
 amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Corporate Officer/Principal | - |
| Lonza Cologne AG | Sales & Marketing | - |
Taconic Biosciences GmbH
 Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Taconic Biosciences GmbH provides research in genetics and functional genomics. It specializes in the generation of genetic models for biomedical research and testing. The company was founded on October 5, 2001 and is headquartered in Leverkusen, Germany. | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Corporate Officer/Principal | - |
Formation de Hartmut Tintrup
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Health Technology |
Taconic Biosciences GmbH
Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Taconic Biosciences GmbH provides research in genetics and functional genomics. It specializes in the generation of genetic models for biomedical research and testing. The company was founded on October 5, 2001 and is headquartered in Leverkusen, Germany. | Commercial Services |
amaxa GmbH
amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Commercial Services |
| Lonza Cologne AG | Health Technology |
Cellbox Solutions GmbH
Cellbox Solutions GmbH Information Technology ServicesTechnology Services Cellbox Solutions GmbH provides innovative logistics solutions for the healthcare industry to transport sensitive biological material and therapeutics that suffer from freezing during shipment but require optimal physiological conditions when transported. The company is based in Cologne, Germany. The German company's portable CO2 incubator, Cellbox, provides a controlled and optimal environment for the transport of living cells, organoids, tissues, and other sensitive biological material. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions. The company was founded in 2017 by Kathrin Adlkofer. Wolfgang Kintzel has been the CEO of the company since 2020. | Technology Services |